Financial Results
FY2020
Next schedule
News Release
-
08.27.2020 Announcement Concerning a COVID-19 Vaccine Development Partnership with VIDO-InterVac at Dalton Chemical Laboratories, Inc.
（127KB）
-
07.31.2020 Consolidated Financial Results for the First Quarter of Fiscal 2020
（107KB）
読む Consolidated Financial Results for the First Quarter of Fiscal 2020
-
06.26.2020 (Update of Previous Disclosure) Seikagaku Announces Completion of Acquisition (Incorporation as a Subsidiary) of Dalton Chemical Laboratories, Inc. and Change in Specified Subsidiaries
（169KB）
-
06.11.2020 Ono and Seikagaku Announce the Results from a Phase III Clinical Study in Japan of ONO-5704/SI-613 in Patients with Knee Osteoarthritis Presented at an Academic Conference
（174KB）
What's New
-
07.31.2020 Seikagaku announced the financial results for the First Quarter of the Fiscal Year ending March 31, 2021
-
07.01.2020 Seikagaku will announce the financial results for the First Quarter of the Fiscal Year ending March 31, 2021 at 15:00 on July 31, 2020.
-
06.19.2020 New Message from President & CEO
-
05.22.2020 Presentation Material for the Briefing on FY2019
